Cite
HARVARD Citation
Mrowietz, U. et al. (2017). Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate‐to‐severe chronic plaque psoriasis: a randomized, double‐blind, Fumaderm®‐ and placebo‐controlled trial (BRIDGE). British journal of dermatology. pp. 615-623. [Online].